(Q42517411)

1 November 2017

title

The transcription factor Forkhead box P3 (FoxP3) is expressed in glioma cells and associated with increased apoptosis (English)

1 reference

1 November 2017

6

1 reference

1 November 2017

Janka Held-Feindt

1

1 reference

1 November 2017

Kirsten Hattermann

2

1 reference

1 November 2017

Susanne Sebens

3

1 reference

1 November 2017

Stefan Krautwald

4

1 reference

1 November 2017

H Maximilian Mehdorn

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 December 2012

1 reference

Experimental Cell Research

1 November 2017

published in

1 reference

1 November 2017

volume

319

1 reference

1 November 2017

issue

5

1 reference

1 November 2017

page(s)

731-739

1 reference

Signalling through FOXP3 as an X-linked tumor suppressor.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Targeting regulatory T cells in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Optimal population of FoxP3+ T cells in tumors requires an antigen priming-dependent trafficking receptor switch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Foxp3 Expression in Pancreatic Carcinoma Cells as a Novel Mechanism of Immune Evasion in Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Foxp3 expression in human cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

FOXP3 expression and overall survival in breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Subcellular localization of FOXP3 in human regulatory and nonregulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Molecular pathology of malignant gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Glioblastoma-derived mechanisms of systemic immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Glioma-associated cancer-initiating cells induce immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Epigenetic mechanisms of regulation of Foxp3 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Foxp3 expression in p53-dependent DNA damage responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.018

10.1016/J.YEXCR.2012.11.018

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference